JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB20008

HRP Anti-HIV1 gp120 antibody

Be the first to review this product! Submit a review

|

(0 Publication)

Goat Polyclonal ENV antibody - conjugated to HRP. Suitable for ELISA, WB and reacts with Human immunodeficiency virus samples.

View Alternative Names

Glycoprotein 120, SU, Surface protein, gp120

Key facts

Host species

Goat

Clonality

Polyclonal

Isotype

IgG

Conjugation

HRP

Excitation/Emission
Carrier free

No

Reacts with

Human immunodeficiency virus

Applications

WB, ELISA

applications

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human immunodeficiency virus": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "1/200 - 1/1000", "ELISA-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "1/20 - 1/200", "WB-species-notes": "<p>Dilution optimised using Chromogenic detection.</p>" } } }
style
left-column

Product details

IgG fraction covalently coupled to a highly purified preparation of horseradish peroxidase (RZ>3). Care is taken to ensure adequate conjugation while preserving maximum enzyme activity. Free enzyme is absent. Estimated molar HRP: IgG substitution is 2-3.
style
left-column

Properties and storage information

Form
Liquid
Purity
IgG fraction
Storage buffer
Preservative: 0.002% Thimerosal (merthiolate) Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HIV1 gp120 also known as glycoprotein 120 is a protein present on the exterior of the Human Immunodeficiency Virus type 1 (HIV-1). This protein is an essential component for the virus's ability to infect host cells. It weighs approximately 120 kDa. Researchers find it abundantly expressed on the surface of HIV-1 virions and it plays an important role in viral entry by binding to the CD4 receptors on host T helper cells. The gp120 protein structure comprises multiple domains each contributing to the binding process which facilitates viral fusion with the host cell membrane.
Biological function summary

The HIV1 gp120 protein functions by facilitating the attachment and entry of the virus into host cells. It is part of a larger glycoprotein complex that also includes gp41 another envelope protein. The interaction of gp120 with CD4 receptors on the host cell surface triggers conformational changes that expose binding sites for coreceptors such as CCR5 or CXCR4 which are necessary for viral entry. These interactions are important for establishing a successful infection and allowing the virus to replicate within the host.

Pathways

The function of HIV1 gp120 significantly impacts several cellular signaling pathways in the host. One critical pathway is the immune response signaling pathway which it modulates to evade detection by the immune system. After gp120 binds to CD4 and a coreceptor it can influence pathways involving cytokine production leading to immune suppression. The relationship between gp120 and gp41 is vital with the latter facilitating membrane fusion after gp120 binding illustrating interdependence within the viral entry pathway.

HIV1 gp120 is directly linked to the progression of Acquired Immunodeficiency Syndrome (AIDS). The protein's ability to hijack CD4 T cells and weaken the immune system plays a major role in the disease's development. The dimerization with gp41 in the viral envelope enhances infection efficiency exacerbating immune depletion. HIV1 gp120 is also implicated in the development of HIV-associated neurocognitive disorders primarily through its interactions with other viral proteins and host cellular receptors leading to neurological complications in infected individuals.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

See full target information HIV1 gp120
style
left-column
style
left-column
style
right-column

Alternative Products

Primary Antibodies

AB85054

Anti-HIV1 gp120 antibody

Western blot - Anti-HIV1 gp120 antibody (AB85054)

  • 0
  • 0
Primary Antibodies

AB106578

Anti-HIV1 gp120 antibody

Western blot - Anti-HIV1 gp120 antibody (AB106578)

  • 4
  • 1
Primary Antibodies

AB53937

Biotin Anti-HIV1 gp120 antibody

  • 0
  • 0
Primary Antibodies

AB21179

Anti-HIV1 gp120 antibody

  • 5
  • 1

Complementary Products

Primary Antibodies

AB21179

Anti-HIV1 gp120 antibody

  • 5
  • 1
Primary Antibodies

AB66643

Anti-HIV1 Vif antibody [319]

Recombinant

Immunocytochemistry/ Immunofluorescence - Anti-HIV1 Vif antibody [319] (AB66643)

  • 0
  • 0
Primary Antibodies

AB203829

Anti-ZEB1 antibody [EPR17375]

RabMAb|Recombinant|KO Validated

Western blot - Anti-ZEB1 antibody [EPR17375] (AB203829)

  • 3
  • 3
Primary Antibodies

AB18207

Anti-beta III Tubulin antibody - Neuronal Marker

BOND RX™ Validated|Lab Essentials|KO Validated

Immunocytochemistry/ Immunofluorescence - Anti-beta III Tubulin antibody - Neuronal Marker (AB18207)

  • 5
  • 67

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com